[Gallbladder complications after bariatric surgery].
With the increased incidence of obesity in the developed countries, and the failure of medical treatments, bariatric surgery has increased rapidly. Although laparoscopic gastroplasty is the most popular bariatric intervention in France, the gold standard tends to be the laparoscopic gastric bypass. The severe weight loss caused by this type of procedure induces specific middle or long term complications such as biliary lithiasis. In this literature we describe different physiopathological mechanisms of lithiasis after gastric bypass by coeliosurgery or gastroplasty, their diagnosis, and preventive treatment to avoid these complications.
Veyrie
Nicolas
N
Unité de chirurgie viscérale et digestive, Hôtel-Dieu, Assistance Publique des Hôpitaux de Paris, Université Paris V René Descartes, Paris, France.
Servajean
Stéphane
S
Berger
Nicolas
N
Loire
Priscille
P
Basdevant
Arnaud
A
Bouillot
Jean-Luc
JL
D000293:Adolescent; D000328:Adult; D000368:Aged; D050110:Bariatric Surgery / Q000009:adverse effects / Q000379:methods; D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000627:therapeutic use; D002763:Cholecystectomy; D002764:Cholecystitis / Q000453:epidemiology / Q000209:etiology; D041761:Cholecystolithiasis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D002769:Cholelithiasis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D019160:Endosonography; D005260:Female; D005705:Gallbladder Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control / Q000601:surgery; D042882:Gallstones / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D015390:Gastric Bypass / Q000009:adverse effects / Q000379:methods; D015391:Gastroplasty / Q000009:adverse effects / Q000379:methods; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use
D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid